1263483-61-9

Basic information

• Product Name: 2-Fluoro-4-(2-{1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,3-oxazol-4-yl)benzoic acid
• Synonyms: 2-Fluoro-4-(2-{1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,3-oxazol-4-yl)benzoic acid
• CAS NO: 1263483-61-9
• Molecular Weight: 451.454
• Mol File: 1263483-61-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-Fluoro-4-(2-{1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,3-oxazol-4-yl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Fluoro-4-(2-{1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,3-oxazol-4-yl)benzoic acid(1263483-61-9)
• EPA Substance Registry System: 2-Fluoro-4-(2-{1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,3-oxazol-4-yl)benzoic acid(1263483-61-9)

Safety Data

• Hazardous Substances Data: 1263483-61-9(Hazardous Substances Data)

Upstream product

• 1263320-49-5 ethyl 2-{4-[amino(hydroxyimino)methyl]phenoxy}butanoate 
• 1263483-59-5 2-(4-Bromo-3-fluorophenyl)-2-oxoethyl 2-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]butanoate 
• 1263483-58-4 2-Diazo-1-(4-bromo-3-fluorophenyl)ethanone 
• 1263320-51-9 2-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]butyric acid 
• 1263320-50-8 ethyl 2-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]butanoate 
• 79228-67-4 Ethyl 2-(4-cyanophenoxy)butanoate 
• 1003879-02-4 2-bromo-1-(4-bromo-3-fluorophenyl)ethanone 
• 767-00-0 4-cyanophenol 
• 201230-82-2 carbon monoxide 
• 1263483-60-8 3-(4-{1-[4-(4-Bromo-3-fluorophenyl)-1,3-oxazol-2-yl]propoxy}phenyl)-5-isopropyl-1,2,4-oxadiazole 
• 153556-42-4 4-bromo-3-fluorobenzoic acid 

Relevant articles and documents

AMIDE DERIVATIVE

Provided are a compound having an excellent hypoglycemic action, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause an increase in the blood sugar level due to abnormal sugar metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.